Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the efficacy and safety of treatment with the drug
eplerenone in patients with chronic central serous chorioretinopathy.